Next Generation Sequencing Market Share & Size Report, 2032

Next Generation Sequencing Market - By Product (Instruments, Consumables, Services), By Application (Research, Clinical), By Type (Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing), Technology, End-use & Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Next generation sequencing industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Product type trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; Type trends

2.1.5&nbsp;&nbsp;&nbsp; Technology trends

2.1.6&nbsp;&nbsp;&nbsp; End-use trends

2.1.7&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Next Generation Sequencing Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing technological advancements in next generation sequencing in developed countries

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing research and development activities in North America and Europe

3.2.1.3&nbsp;&nbsp;&nbsp;Growing use of NGS technology by pharmaceutical and biopharmaceutical companies in advanced economies

3.2.1.4&nbsp;&nbsp;&nbsp;Favorable regulatory scenario in North America

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Dearth of skilled professionals

3.2.2.2&nbsp;&nbsp;&nbsp;High cost of next generation sequencing

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By product type

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By type

3.3.4&nbsp;&nbsp;&nbsp; By technology

3.3.5&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

4.1.2&nbsp;&nbsp;&nbsp; BGI, Bio-Rad Laboratories

4.1.3&nbsp;&nbsp;&nbsp; F Hoffmann-La Roche

4.2&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Next Generation Sequencing Market, By Product Type

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Instruments

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Consumables

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Services

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Next Generation Sequencing Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key segment trends

6.2&nbsp;&nbsp;&nbsp; Research

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Clinical

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.2&nbsp;&nbsp;&nbsp; Cardiovascular

6.3.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.3&nbsp;&nbsp;&nbsp; Reproductive health

6.3.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.4&nbsp;&nbsp;&nbsp; Cancer

6.3.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.5&nbsp;&nbsp;&nbsp; Infectious diseases

6.3.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.6&nbsp;&nbsp;&nbsp; Others

6.3.6.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Others

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Next Generation Sequencing Market, By Type

7.1&nbsp;&nbsp;&nbsp; Key segment trends

7.2&nbsp;&nbsp;&nbsp; Whole genome sequencing (WGS)

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Exome sequencing

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Targeted sequencing

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Others

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Next Generation Sequencing Market, By Technology

8.1&nbsp;&nbsp;&nbsp; Key segment trends

8.2&nbsp;&nbsp;&nbsp; Sequencing by synthesis

8.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.3&nbsp;&nbsp;&nbsp; Ion semiconductor sequencing

8.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.4&nbsp;&nbsp;&nbsp; Other

8.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9&nbsp;&nbsp;&nbsp;Next Generation Sequencing Market, By End-use

9.1&nbsp;&nbsp;&nbsp; Key segment trends

9.2&nbsp;&nbsp;&nbsp; Academic institutes &amp; research centers

9.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.3&nbsp;&nbsp;&nbsp; Hospitals &amp; clinics

9.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.4&nbsp;&nbsp;&nbsp; Pharmaceutical &amp; biotechnology companies

9.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

9.5&nbsp;&nbsp;&nbsp; Others

9.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 10&nbsp;&nbsp;&nbsp;Next Generation Sequencing Market Market, By Region

10.1&nbsp;&nbsp;&nbsp; Key regional trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Poland

10.3.7&nbsp;&nbsp;&nbsp; Switzerland

10.3.8&nbsp;&nbsp;&nbsp; Sweden

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; China

10.4.2&nbsp;&nbsp;&nbsp; India

10.4.3&nbsp;&nbsp;&nbsp; Japan

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; South Korea

10.4.6&nbsp;&nbsp;&nbsp; Thailand

10.4.7&nbsp;&nbsp;&nbsp; Indonesia

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Columbia

10.5.5&nbsp;&nbsp;&nbsp; Chile

10.5.6&nbsp;&nbsp;&nbsp; Peru

10.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

10.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.2&nbsp;&nbsp;&nbsp; South Africa

10.6.3&nbsp;&nbsp;&nbsp; UAE

10.6.4&nbsp;&nbsp;&nbsp; Israel

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; 10X Genomics

11.2&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

11.3&nbsp;&nbsp;&nbsp; BGI

11.4&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

11.5&nbsp;&nbsp;&nbsp; F Hoffmann-La Roche

11.6&nbsp;&nbsp;&nbsp; GenapSys Inc.

11.7&nbsp;&nbsp;&nbsp; Illumina, Inc.

11.8&nbsp;&nbsp;&nbsp; NanoString Technologies, Inc.

11.9&nbsp;&nbsp;&nbsp; Oxford Nanopore Technologies

11.10&nbsp;&nbsp;&nbsp; Pacific Biosciences of California, Inc.

11.11&nbsp;&nbsp;&nbsp; PerkinElmer Inc.

11.12&nbsp;&nbsp;&nbsp; Qiagen

11.13&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

&nbsp;&nbsp;&nbsp;

Next Generation Sequencing Market

Inquiry Before Buying

Industries

Information

Link

Global Headquarters